{
  "id": 6553503,
  "title": "Hexiris Ophthalmics to Present First-in-Human OBi Glaucoma Data at Five Fall Meetings, Beginning with the Ophthalmology Futures Forum in London",
  "url": "https://urgent.news/2026/09/10/hexiris-ophthalmics-to-present-first-in-human-obi-glaucoma-data-at",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-10T06:04:58.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/globe-newswire/hexiris-ophthalmics-to-present-first-in-human-obi-glaucoma-data-at-five-fall-meetings-beginning-with-the-ophthalmology-futures-forum-in-london"
  },
  "original_language": "en",
  "account": null,
  "summary": "Physician-founded company will bring its office-based interventional glaucoma platform to Ophthalmology Futures, ESCRS, Sally Letson, CGS and AAO 2026 DIEPPE, New Brunswick, Sept. 10, 2026 (GLOBE NEWSWIRE) — Hexiris Ophthalmics, a physician-founded developer of interventional glaucoma technologies, today announced a fall program spanning five major ophthalmology meetings in Europe and North…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}